The Canadian Air Transport Security Authority (CATSA) has awarded a standing offer to Implant Sciences for 340 QS-B220 desktop explosives trace detectors (ETD).

As part of the offer, the company will deploy its QS-B220 detectors for passenger and baggage screening at Canadian airports over the next two years.

Implant Sciences Americas general manager Todd Swearingen said: "Our robust systems, continue to be deployed in airports globally, deliver highly accurate and effective screening to the travelling public.

"Our robust systems, continue to be deployed in airports globally, deliver highly accurate and effective screening to the travelling public."

"We pride ourselves in supporting the mission of safeguarding passengers around the world, and we are excited to have been selected again by CATSA."

This latest offer from CATSA follows a competitive bid for 112 QS-B220 ETDs, which the company won last year.

Implant Sciences executive vice-president Dr. Darryl Jones added: "Our goal, as the pioneers of non-rad ETD, is to advance our products to meet the evolving needs of our customers and to surpass the performance and detection limitations of legacy trace detectors that are currently fielded."

Introduced in May 2011, the Quantum Sniffer QS-B220 is a desktop explosives and narcotics trace detector featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system.

The ETD features a high-resolution colour touch-screen for audio and visual alarm indications, including substance identification.

It uses non-radioactive ion mobility spectrometry (IMS) analysis technology to quickly detect and identify trace amounts of a range of military, commercial, and homemade explosives.

In 2015, the company’s ETDs have been deployed to more than 160 airports.